| Alzheimer |
| Brain diseases |
| Research |
| Tau |
| APP |
| Abeta |
| VCDN group |
 |
| ALS/PDC Guam |
| AGD |
| Bri |
| CBD |
|
DLDH |
| DM1 |
| Down S |
| GSS |
| FTD |
| FTDP-17 |
| Huntington |
| Hallenvorden |
| IBM |
| Lewy BD |
| MSA |
| NPiD c |
| Parkinson D Guadeloupe |
| Parkinson |
| Dementia in Parkinson |
| Pick |
| Prion |
| PSP |
| PEP |
| Semantic D |
|
SSP |
| ToD |
Truncated beta-amyloid peptide species in pre-clinical Alzheimer’s disease as new targets for the vaccination approach
Nicolas Sergeant, Stepanie Bombois, Antoine Ghestem, Herve Drobecq, Vesna
Kostanjevecki, Carla Missiaen, Annick Wattez, Jean-Phillipe David, Eugeen
Vanmechelen, Christian Sergheraert and Andre Delacourte.
J. Neurochem. (2003) 85,
1581–1591. Journal of Neurochemistry, 2003, 85, 1581–1591
| Alzheimer |
 |
| Research |
| Tau |
| APP |
| Ab |
| ApoE |
| catenin |
| NSE |
| Parkin |
| Pin1 |
| Presenilins, |
| Proteasome |
| Synuclein |
| Ubiquitin |